These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25200117)
1. Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV. Grishchuk Y; Sri S; Rudinskiy N; Ma W; Stember KG; Cottle MW; Sapp E; Difiglia M; Muzikansky A; Betensky RA; Wong AM; Bacskai BJ; Hyman BT; Kelleher RJ; Cooper JD; Slaugenhaupt SA Acta Neuropathol Commun; 2014 Sep; 2():133. PubMed ID: 25200117 [TBL] [Abstract][Full Text] [Related]
2. Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV. Grishchuk Y; Peña KA; Coblentz J; King VE; Humphrey DM; Wang SL; Kiselyov KI; Slaugenhaupt SA Dis Model Mech; 2015 Dec; 8(12):1591-601. PubMed ID: 26398942 [TBL] [Abstract][Full Text] [Related]
3. Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV. Mepyans M; Andrzejczuk L; Sosa J; Smith S; Herron S; DeRosa S; Slaugenhaupt SA; Misko A; Grishchuk Y; Kiselyov K Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586947 [TBL] [Abstract][Full Text] [Related]
4. N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV. Boudewyn LC; Sikora J; Kuchar L; Ledvinova J; Grishchuk Y; Wang SL; Dobrenis K; Walkley SU Neurobiol Dis; 2017 Sep; 105():257-270. PubMed ID: 28610891 [TBL] [Abstract][Full Text] [Related]
6. Progress in elucidating pathophysiology of mucolipidosis IV. Misko A; Wood L; Kiselyov K; Slaugenhaupt S; Grishchuk Y Neurosci Lett; 2021 Jun; 755():135944. PubMed ID: 33965501 [TBL] [Abstract][Full Text] [Related]
7. Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV. Micsenyi MC; Dobrenis K; Stephney G; Pickel J; Vanier MT; Slaugenhaupt SA; Walkley SU J Neuropathol Exp Neurol; 2009 Feb; 68(2):125-35. PubMed ID: 19151629 [TBL] [Abstract][Full Text] [Related]
8. MCOLN1 gene therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV. DeRosa S; Salani M; Smith S; Sangster M; Miller-Browne V; Wassmer S; Xiao R; Vandenberghe L; Slaugenhaupt S; Misko A; Grishchuk Y Hum Mol Genet; 2021 May; 30(10):908-922. PubMed ID: 33822942 [TBL] [Abstract][Full Text] [Related]
9. Association of luteal cell degeneration and progesterone deficiency with lysosomal storage disorder mucolipidosis type IV in Mcoln1-/- mouse model†. Wang Z; El Zowalaty AE; Li Y; Andersen CL; Ye X Biol Reprod; 2019 Oct; 101(4):782-790. PubMed ID: 31317194 [TBL] [Abstract][Full Text] [Related]
10. Suppression of the motor deficit in a mucolipidosis type IV mouse model by bone marrow transplantation. Walker MT; Montell C Hum Mol Genet; 2016 Jul; 25(13):2752-2761. PubMed ID: 27270598 [TBL] [Abstract][Full Text] [Related]
12. White matter abnormalities and iron deposition in prenatal mucolipidosis IV- fetal imaging and pathology. Zerem A; Ben-Sira L; Vigdorovich N; Leibovitz Z; Fisher Y; Schiffmann R; Grishchuk Y; Misko AL; Orenstein N; Lev D; Lerman-Sagie T; Kidron D Metab Brain Dis; 2021 Oct; 36(7):2155-2167. PubMed ID: 33963976 [TBL] [Abstract][Full Text] [Related]
13. Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV. Li H; Pei W; Vergarajauregui S; Zerfas PM; Raben N; Burgess SM; Puertollano R Hum Mol Genet; 2017 Jul; 26(14):2701-2718. PubMed ID: 28449103 [TBL] [Abstract][Full Text] [Related]
14. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Venugopal B; Browning MF; Curcio-Morelli C; Varro A; Michaud N; Nanthakumar N; Walkley SU; Pickel J; Slaugenhaupt SA Am J Hum Genet; 2007 Nov; 81(5):1070-83. PubMed ID: 17924347 [TBL] [Abstract][Full Text] [Related]
15. Mucolipidosis type IV: an update. Wakabayashi K; Gustafson AM; Sidransky E; Goldin E Mol Genet Metab; 2011 Nov; 104(3):206-13. PubMed ID: 21763169 [TBL] [Abstract][Full Text] [Related]